Wednesday, March 18, 2026 3/18/2026

Synthesis and transport of outer membrane components across the Gram-negative cell envelope

Award Number: R01AI176776
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/27/2023
PERIOD OF PERFORMANCE END DATE: 12/31/2027

Group Awards By:

View Award Description

Synthesis and transport of outer membrane components across the Gram-negative cell envelope - Abstract The increasing rise in antibiotic resistance and the diminished discovery of new antimicrobials threatens global healthcare. Of particular concern are Gram-negative pathogens, organisms with an additional outer membrane (OM) that provides intrinsic resistance to multiple classes of antibiotics. Unlike the inner membrane (IM) that is composed solely of glycerophospholipids (GPLs), the OM is asymmetrical with GPLs found in the inner leaflet and lipopolysaccharide (LPS) localized to the outer leaflet. This unique membrane asymmetry affords protection from large polar molecules, as well as lipophilic compounds, creating an impervious barrier. Since the OM is essential, pathways required for its assembly are key targets for antimicrobial design. Currently, there are no antibiotics that directly target OM biogenesis in clinical use. Thus, it remains critical to investigate cell envelope biogenesis for future and current antimicrobial design. Over the last few decades, we have expanded our understanding of OM assembly revealing new targets for antimicrobial design. However, one major gap remained. How are GPLs transported from the IM to the OM across the aqueous periplasm? Recently, we discovered that key members of the AsmA-like family (YhdP, TamB, and YdbH) are critical for OM integrity and involved in GPL transport. We found that YhdP, TamB, and YdbH are redundant in their role in OM lipid homeostasis; however, they are not equivalent. Notably, all three proteins share homology and structural features with eukaryotic GPL transporters and are capable of spanning the periplasm. The overall objective of this application is to investigate the molecular mechanisms required for the assembly and maintenance of the Gram-negative OM. More specifically, we will characterize pathways required to transport GPLs across the cell envelope using E. coli as the model system. In the current application we will (i) characterize the major GPL transporters (YhdP, TamB, and YdbH), (ii) identify accessory proteins required for GPL transbilayer movement, and (iii) determine how loss of these systems impact OM lipid homeostasis and antibiotic resistance.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $640,850 )
2026	2026	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 E CAMPUS RD RM 409	ATHENS	GA	30602	CLARKE	USA	Allergy and Infectious Diseases Research	000	4	12/31/2025	NON-COMPETING CONTINUATION	$640,850
														Subtotal = $640,850

Issue Date FY: 2025 ( Subtotal = $640,850 )
2025	2025	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 E CAMPUS RD RM 409	ATHENS	GA	30602	CLARKE	USA	Allergy and Infectious Diseases Research	000	3	12/23/2024	NON-COMPETING CONTINUATION	$640,850
														Subtotal = $640,850

Issue Date FY: 2024 ( Subtotal = $661,538 )
2024	2024	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 E CAMPUS RD RM 409	ATHENS	GA	30602	CLARKE	USA	Allergy and Infectious Diseases Research	000	2	12/14/2023	NON-COMPETING CONTINUATION	$595,384
2024	2024	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 E CAMPUS RD RM 409	ATHENS	GA	30602	CLARKE	USA	Allergy and Infectious Diseases Research	001	2	5/21/2024	NON-COMPETING CONTINUATION	$66,154
														Subtotal = $661,538

Issue Date FY: 2023 ( Subtotal = $579,785 )
2023	2023	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 EAST CAMPUS RD TUCKER HALL ROOM 409	ATHENS	GA	30602	CLARKE	USA	Allergy and Infectious Diseases Research	000	1	1/27/2023	NEW	$579,785
														Subtotal = $579,785

Grand Total All Awards = $2,523,023

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Synthesis and transport of outer membrane components across the Gram-negative cell envelope

Award Number: R01AI176776

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/27/2023

PERIOD OF PERFORMANCE END DATE: 12/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer